Canada Pension Plan Investment Board
ABUS icon

Canada Pension Plan Investment Board’s Arbutus Biopharma ABUS Stock Holding History

Canada Pension Plan Investment Board’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-233,800
Closed -$4.08M – 1275
2015
Q1 		$4.08M Hold
233,800
– – 0.02% 641
2014
Q4 		$3.59M Buy
233,800
+57,100
+32% +$985K 0.01% 673
2014
Q3 		$3.75M Buy
+176,700
New +$2.89M 0.01% 650

Other funds holding ABUS

QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Canada Pension Plan Investment Board's ABUS Position: Q2 2015 in Review

Canada Pension Plan Investment Board sold out of Arbutus Biopharma (ABUS) in Q2 2015, closing a stake of 233,800 shares — an estimated $4.08M sold.

Canada Pension Plan Investment Board first reported a position in ABUS in Q3 2014 and held it in 3 quarters. The position peaked at $4.08M in Q1 2015. 63 funds tracked by Wall St. Rank hold ABUS as of Q2 2015.

  • Canada Pension Plan Investment Board reported no remaining Arbutus Biopharma position as of Q2 2015 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 233,800 Arbutus Biopharma shares in Q2 2015, an estimated $4.08M.
  • Canada Pension Plan Investment Board first reported a position in Arbutus Biopharma in Q3 2014 and held it in 3 quarters.
  • Canada Pension Plan Investment Board's Arbutus Biopharma position peaked at $4.08M in Q1 2015.
  • 63 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2015.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2015, filed 12 Aug 2015.